Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
508
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System

Christopher R. Freia South Texas Veterans Health Care System, San Antonio, TX, USA;b College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA;c Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0692-4787View further author information
ORCID Icon,
Hannah Led AstraZeneca US Medical Affairs, Gaithersburg, MD, USAView further author information
,
Daniel McHughd AstraZeneca US Medical Affairs, Gaithersburg, MD, USAView further author information
,
Kellie Ryand AstraZeneca US Medical Affairs, Gaithersburg, MD, USAView further author information
,
Xavier Jonesa South Texas Veterans Health Care System, San Antonio, TX, USA;b College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA;c Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
,
Samantha Galleya South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Kathleen Franklina South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Courtney J. Bausb College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA;c Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
,
Juan Taveraa South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Michelle Janania-Martineza South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
David Gregorioa South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Snegha Anantha South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Ricardo Uribea South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Prathibha Surapanenia South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Manuel Espinoza-Gutarraa South Texas Veterans Health Care System, San Antonio, TX, USAORCID Iconhttps://orcid.org/0000-0002-7906-8782View further author information
ORCID Icon,
Michael M. Songa South Texas Veterans Health Care System, San Antonio, TX, USAView further author information
,
Chengwen Tenge Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, The University of South Carolina, Columbia, SC, USAORCID Iconhttps://orcid.org/0000-0001-9239-2125View further author information
ORCID Icon,
Obiageri O. Obodozie-Ofoegbub College of Pharmacy, The University of Texas at Austin, San Antonio, TX, USA;c Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
&
Zohra Nooruddina South Texas Veterans Health Care System, San Antonio, TX, USA;c Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USAORCID Iconhttps://orcid.org/0000-0003-4659-4310View further author information
ORCID Icon show all
Pages 1664-1673 | Received 02 Oct 2020, Accepted 10 Jan 2021, Published online: 11 Feb 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rania S. Khelifi, Steven J. Huang, Kerry J. Savage, Diego Villa, David W. Scott, Khaled Ramadan, Joseph M. Connors, Laurie H. Sehn, Cynthia L. Toze & Alina S. Gerrie. (2023) Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada. Leukemia & Lymphoma 64:6, pages 1129-1138.
Read now

Articles from other publishers (3)

Kana Tai LuceroObiageri O Obodozie-OfoegbuZohra NooruddinKellie RyanAlyssa CastilloAmanda M MooreXavier JonesChristopher R Frei. (2023) Health disparity in use of novel agents for first-line therapy in Black and White patients with chronic lymphocytic leukemia in the Department of Veterans Affairs. Journal of Managed Care & Specialty Pharmacy 29:4, pages 420-430.
Crossref
Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, Alessandro Sanna, Emilia Iannella, Morena Caira, Paola Finsinger, Silvia Schifano, Benedetta Neri, Stefano Molica & Francesca Romana Mauro. (2023) Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience. Hematological Oncology.
Crossref
Jennifer A. Woyach, Paul M. Barr, Thomas J. Kipps, Jacqueline C. Barrientos, Inhye E. Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain & Jan A. Burger. (2023) Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers 15:2, pages 507.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.